Cultural Competence and Indigenous Health — Written Clinical Reasoning

Prompt 1: The Indigenous patient with chronic disease (30 marks, 25 minutes)

Scenario. A 48-year-old Aboriginal woman from a remote community 800 km from the metropolitan hospital is admitted with decompensated heart failure. Echocardiography confirms severe rheumatic mitral stenosis (mitral valve area 0.9 cm2) with moderate mitral regurgitation and mild aortic regurgitation. She has type 2 diabetes (HbA1c 84 mmol/mol), stage 3B chronic kidney disease (eGFR 38, ACR 65 mg/mmol), chronic suppurative otitis media with bilateral conductive hearing loss, and depression. She was diagnosed with acute rheumatic fever at age 12 and is supposed to receive benzathine penicillin G every 28 days, but has missed four of her last six injections. She is 800 km from home, has not seen an Aboriginal Health Worker during this admission, and the nursing notes describe her as 'non-compliant'. She has a 14-year-old son at home who cares for her when she is unwell. [1]

Question. Discuss the integrated assessment and management of this patient, including: (a) the prioritised problem list; (b) the immediate management of her decompensated heart failure; (c) the approach to her suboptimal secondary prophylaxis adherence; (d) the management of her diabetes and chronic kidney disease; (e) the cultural and social dimensions of her care and how you will address them; and (f) the discharge plan. [1]

Model answer

(a) Prioritised problem list. [1]

1. Decompensated heart failure from severe rheumatic mitral stenosis with mixed mitral disease (stenosis plus regurgitation) and mild aortic regurgitation — rheumatic in origin
2. Suboptimal secondary prophylaxis for rheumatic heart disease (missed 4 of 6 benzathine penicillin injections) with risk of recurrent ARF and further valvular damage
3. Type 2 diabetes mellitus with poor glycaemic control (HbA1c 84 mmol/mol)
4. Chronic kidney disease stage 3B (eGFR 38) with albuminuria (ACR 65 mg/mmol) — diabetic kidney disease
5. Chronic suppurative otitis media with bilateral conductive hearing loss — affecting communication and reflecting chronic disadvantage
6. Depression (under-treated)
7. Social and cultural context: 800 km from home and community, adolescent son as carer, no Aboriginal Health Worker involved, documented as 'non-compliant' (a framing that itself reflects a failure of cultural safety), and a history of disengagement from the health system [1]

(b) Immediate management of decompensated heart failure. [1]

The patient is in decompensated heart failure from critical mitral stenosis. The immediate management includes: oxygen if hypoxic; diuretics (intravenous frusemide, titrated to urine output and weight, monitoring electrolytes and renal function given the baseline CKD); rate control if atrial fibrillation is present (the patient with mitral stenosis and decompensated heart failure is at high risk of AF, which causes rapid deterioration — the physician should check the ECG and control the rate with a beta-blocker or digoxin, avoiding verapamil or diltiazem in heart failure); anticoagulation if AF is present (the patient with mitral stenosis and AF has a high stroke risk). The definitive management of severe symptomatic mitral stenosis is mechanical intervention — percutaneous balloon mitral valvuloplasty if the valve morphology is suitable (pliable, no heavy calcification, no left atrial thrombus, no more than moderate mitral regurgitation), or surgical mitral valve replacement if the valve is not suitable for valvuloplasty. This should be discussed with the cardiothoracic and interventional cardiology teams early. [1]

(c) Approach to suboptimal secondary prophylaxis adherence. [1]

The missed injections are not a patient failure but a system failure. The physician must ask why the injections were missed — transport barriers, the pain of the injection, lack of a local nurse-led program, cultural safety of the service, the patient's understanding of why the injection matters, or practical barriers (childcare, work, distance). The response is to: involve the Aboriginal Health Worker and the community-controlled health service; explain (using teach-back and an interpreter if needed) the rationale for the injection and the consequences of recurrence; address the practical barriers (transport through the patient assistance travel scheme, pain management with lignocaine as diluent, ice, and a consistent nurse); re-establish the patient on the register and recall system; and arrange for the injections to be delivered closer to home through the outreach or community-based program. The physician must reframe the nursing notes: this is not 'non-compliance' but a failure of the system to deliver a culturally safe, accessible service. [1]

(d) Management of diabetes and chronic kidney disease. [1]

The patient has diabetic kidney disease with significant albuminuria and stage 3B CKD. The management includes: glycaemic control — metformin dose-adjusted for eGFR (500 mg twice daily is safe at eGFR 38), plus an SGLT2 inhibitor (dapagliflozin or empagliflozin) for renal and cardiovascular protection (initiate and monitor), and consider adding insulin given the HbA1c of 84 mmol/mol and the long-standing disease; renin-angiotensin system blockade — an ACE inhibitor (or ARB) titrated to the maximum tolerated dose for albuminuria, monitoring potassium and creatinine; blood pressure control to target below 130/80 if albuminuria; statin therapy (this patient is high cardiovascular risk); and screening for retinopathy (fundal photography, possibly via telehealth) and neuropathy (foot examination). The physician should involve the diabetes educator, the dietitian, and the renal team for shared care, and consider early referral to nephrology given the trajectory. [1]

(e) Cultural and social dimensions. [1]

The physician must address the cultural and social dimensions explicitly, as they are as important as the biomedical management. The patient is 800 km from home, isolated from her family and community, frightened, and in a system that has labelled her 'non-compliant'. The physician must: involve the Aboriginal Liaison Officer from the outset; ask the patient about her cultural needs and preferences; use a professional interpreter if there is any language barrier; address the hearing loss (amplification, written information, facing the patient when speaking); explore the social situation (who is caring for her son, what is her housing situation, what are her obligations to her community); be aware of Sorry Business and kinship obligations; and reflect on the team's own framing of the patient as 'non-compliant'. The depression must be assessed and treated, with involvement of the Indigenous mental health service. [1]

(f) Discharge plan. [1]

The discharge plan must be culturally safe, community-based, and realistic. It includes: the heart failure medications and the plan for definitive valve intervention (coordinating with the cardiology outreach service and the community clinic); the re-established secondary prophylaxis delivered by the community nurse; the diabetes and CKD management coordinated through the Aboriginal Medical Service and the specialist outreach team; the mental health follow-up through the Indigenous mental health service; and the social supports (transport, the patient assistance travel scheme, and contact with her son). The plan should be documented in the shared care record, communicated to the community-controlled health service, and reviewed with the patient using teach-back to confirm she understands and agrees. [1]

Prompt 2: The Maori patient with premature cardiovascular disease (20 marks, 15 minutes)

Scenario. A 42-year-old Maori man presents to his general practitioner in Auckland, New Zealand, with a blood pressure of 168/104 mmHg on repeated measurement. He has a 20-pack-year smoking history, a body mass index of 33, and a family history of his father dying of myocardial infarction at age 49. His urine ACR is 48 mg/mmol, eGFR 72, total cholesterol 6.2 mmol/L, LDL 4.1 mmol/L, and HbA1c 42 mmol/mol (pre-diabetes range). [1]

Question. Discuss the culturally appropriate approach to this patient, including: (a) the cardiovascular risk assessment and its interpretation for a Maori patient; (b) the pharmacological management; (c) the application of the Treaty of Waitangi principles and Maori health frameworks to his care; and (d) the role of Whanau Ora. [1]

Model answer

(a) Cardiovascular risk assessment. [1]

This patient has multiple cardiovascular risk factors (hypertension, smoking, obesity, family history of premature cardiovascular death, pre-diabetes, albuminuria) and is Maori, a population that experiences cardiovascular disease earlier and with higher mortality than non-Maori. The cardiovascular risk should be assessed using a validated tool, but the physician must recognise that tools derived from non-Maori populations may systematically underestimate risk in Maori. The presence of albuminuria (ACR 48 mg/mmol) indicates early diabetic or hypertensive kidney disease, which itself places him in a high-risk category regardless of the calculated score. The physician should treat this patient as high cardiovascular risk. [1]

(b) Pharmacological management. [1]

The pharmacological management includes: an ACE inhibitor (or ARB) for hypertension and albuminuria — titrated to the maximum tolerated dose, monitoring potassium and creatinine; a statin (atorvastatin 40 to 80 mg) given the high-risk status; consideration of antiplatelet therapy (aspirin) depending on the absolute risk and bleeding risk; and an SGLT2 inhibitor for the renal and cardiovascular protection given the albuminuria and pre-diabetes. Smoking cessation is the single highest-impact intervention and should be addressed with behavioural support and pharmacotherapy (nicotine replacement therapy, varenicline, or bupropion), delivered through a culturally appropriate program. Blood pressure target should be below 130/80 given the albuminuria. [1]

(c) Treaty of Waitangi principles and Maori health frameworks. [1]

The culturally appropriate approach is grounded in the Treaty of Waitangi. Partnership means working with Maori at all levels — the physician works with the Maori health service, the kaitakawaenga (Maori health worker), and the Maori governance of the primary health organisation. Participation means involving the patient and his whanau in decisions about his care, connecting him to Maori health programs, and supporting his active engagement. Protection means ensuring he receives at least the standard of care that a non-Maori patient receives (which the evidence shows does not always happen) and that his cultural values and practices are safeguarded. The assessment should be framed using Te Whare Tapa Wha — the physician addresses te taha tinana (the physical disease), te taha hinengaro (the mental and emotional dimension — is he stressed, is there depression, what is his relationship with smoking), te taha whanau (who is at home, who supports him, is the family affected by the cardiovascular history), and te taha wairua (what gives him strength, are there cultural or spiritual practices the team should support). [1]

(d) Role of Whanau Ora. [1]

Whanau Ora is the family-centred model of service delivery. A whanau ora navigator (kaiarahi) works with the whanau to identify their goals and coordinates the health, education and social services they need. For this patient, Whanau Ora means the management plan is designed around the whanau — the smoking cessation may involve the whole household, the dietary changes may involve the person who cooks, the physical activity may be a whanau activity, and the follow-up may be through a marae-based or community-based program. The physician supports this by making the whanau part of the plan, by accepting that decisions may be made collectively, and by connecting the patient to the whanau ora service where available. This shifts the model from the individual patient with a risk factor to the family with a life, which is the Maori health framework. [1]